Notice Information
Notice Title
Cytokine Modulators
Notice Description
Supply of Cytokine Modulators to NHS Scotland which is used to treat licensed indications. Etanercept Infliximab Adalimumab Methotrexate The Goods have been split into eight (8) categories, each of which are identified as a "Lot". Full details of each Lot are contained in section II.2 of this notice.
Lot Information
Adalimumab
Supply of Adalimumab to NHS Scotland. The Authority has awarded this Lot as a unranked multi-supplier framework per line to five (5) Framework Participants.
Renewal: This framework includes the option(s) to extend for up to a total period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
EtanerceptSupply of Etanercept to NHS Scotland. The Authority has awarded this Lot as a unranked multi-supplier framework per line to three (3) Framework Participants.
Renewal: This framework includes the option(s) to extend for up to a total period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Infliximab IVSupply of Infliximab IV to NHS Scotland. The Authority has awarded this Lot as a unranked multi-supplier framework per line to five (5) Framework Participants.
Renewal: This framework includes the option(s) to extend for up to a total period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Methotrexate (50 mg per 1 ml concentration ) pre-filled self injection deviceSupply of Methotrexate (50 mg per 1 ml concentration ) pre-filled self injection device to NHS Scotland. The Authority has awarded this Lot as a unranked multi-supplier framework per line to two (2) Framework Participants.
Renewal: This framework includes the option(s) to extend for up to a total period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Methotrexate (50 mg per 1 ml concentration ) pre-filled syringesSupply of Methotrexate (50 mg per 1 ml concentration ) pre-filled syringes to NHS Scotland. The Authority has awarded this Lot as a unranked multi-supplier framework per line to one (1) Framework Participant.
Renewal: This framework includes the option(s) to extend for up to a total period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Methotrexate (25 mg per 1 ml concentration ) pre-filled self injection deviceSupply of Methotrexate (25mg per 1 ml concentration ) pre-filled self injection device to NHS Scotland. The Authority has awarded this Lot as a unranked multi-supplier framework per line to one (1) Framework Participant.
Renewal: This framework includes the option(s) to extend for up to a total period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Methotrexate (25mg per 1 ml concentration ) pre-filled syringesSupply of Methotrexate (25 mg per 1 ml concentration) pre-filled syringes to NHS Scotland. The Authority has awarded this Lot as a unranked multi-supplier framework per line to one (1) Framework Participant.
Renewal: This framework includes the option(s) to extend for up to a total period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Infliximab SubcutaneousSupply of Infliximab Subcutaneous to NHS Scotland. The Authority has awarded this Lot as a single supplier framework per line to one (1) Framework Participant.
Renewal: This framework includes the option(s) to extend for up to a total period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-r6ebe6-0000631656
- Publication Source
- Public Contracts Scotland
- Latest Notice
- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=FEB406448
- Current Stage
- Award
- All Stages
- Tender, Award
Procurement Classification
- Notice Type
- OJEU - F3 - Contract Award Notice
- Procurement Type
- Framework
- Procurement Category
- Goods
- Procurement Method
- Open
- Procurement Method Details
- Open procedure
- Tender Suitability
- Not specified
- Awardee Scale
- Large, SME
Common Procurement Vocabulary (CPV)
- CPV Divisions
33 - Medical equipments, pharmaceuticals and personal care products
-
- CPV Codes
33600000 - Pharmaceutical products
Notice Value(s)
- Tender Value
- £146,393,864 £100M-£1B
- Lots Value
- £146,393,863 £100M-£1B
- Awards Value
- Not specified
- Contracts Value
- £116,643,215 £100M-£1B
Notice Dates
- Publication Date
- 11 Feb 20215 years ago
- Submission Deadline
- 12 Nov 2020Expired
- Future Notice Date
- Not specified
- Award Date
- 11 Jan 20215 years ago
- Contract Period
- Not specified - Not specified
- Recurrence
- Not specified
Notice Status
- Tender Status
- Complete
- Lots Status
- Complete
- Awards Status
- Not Specified
- Contracts Status
- Active
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS")
- Contact Name
- Stephanie McNiven
- Contact Email
- loraine.hartley@nhs.scot, stephanie.mcniven2@nhs.scot
- Contact Phone
- +44 1698794410, +44 2756366
Buyer Location
- Locality
- EDINBURGH
- Postcode
- EH12 9EB
- Post Town
- Edinburgh
- Country
- Scotland
-
- Major Region (ITL 1)
- TLM Scotland
- Basic Region (ITL 2)
- TLM1 East Central Scotland
- Small Region (ITL 3)
- TLM13 City of Edinburgh
- Delivery Location
- TLM Scotland
-
- Local Authority
- City of Edinburgh
- Electoral Ward
- Drum Brae/Gyle
- Westminster Constituency
- Edinburgh South West
Further Information
Notice Documents
-
https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=OCT396897
Cytokine Modulators - Supply of Cytokine Modulators to NHS Scotland. Etanercept Infliximab Adalimumab Methotrexate The Goods have been split into eight (8) categories, each of which are identified as a "Lot". Full details of each Lot are contained in section II.2 of this notice. -
https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=FEB406448
Cytokine Modulators - Supply of Cytokine Modulators to NHS Scotland which is used to treat licensed indications. Etanercept Infliximab Adalimumab Methotrexate The Goods have been split into eight (8) categories, each of which are identified as a "Lot". Full details of each Lot are contained in section II.2 of this notice.
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-r6ebe6-0000631656-2021-02-11T00:00:00Z",
"date": "2021-02-11T00:00:00Z",
"ocid": "ocds-r6ebe6-0000631656",
"initiationType": "tender",
"parties": [
{
"id": "org-20",
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")",
"identifier": {
"legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")"
},
"address": {
"streetAddress": "Gyle Square (NSS Head Office), 1 South Gyle Crescent",
"locality": "Edinburgh",
"region": "UKM",
"postalCode": "EH12 9EB"
},
"contactPoint": {
"name": "Stephanie McNiven",
"email": "Stephanie.McNiven2@nhs.scot",
"telephone": "+44 1698794410",
"url": "https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html"
},
"roles": [
"buyer",
"centralPurchasingBody"
],
"details": {
"classifications": [
{
"id": "Body governed by public law",
"scheme": "TED_CA_TYPE"
},
{
"id": "07",
"description": "Health",
"scheme": "COFOG"
}
],
"url": "http://www.nhsscotlandprocurement.scot.nhs.uk/"
}
},
{
"id": "org-21",
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")",
"identifier": {
"legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")"
},
"address": {
"streetAddress": "Gyle Square (NSS Head Office), 1 South Gyle Crescent",
"locality": "Edinburgh",
"postalCode": "EH12 9EB",
"region": "UKM"
},
"contactPoint": {
"email": "loraine.hartley@nhs.scot",
"telephone": "+44 2756366",
"url": "http://"
},
"roles": [
"buyer",
"centralPurchasingBody"
],
"details": {
"classifications": [
{
"id": "Body governed by public law",
"scheme": "TED_CA_TYPE"
},
{
"id": "07",
"description": "Health",
"scheme": "COFOG"
}
],
"url": "http://www.nhsscotlandprocurement.scot.nhs.uk/"
}
},
{
"id": "org-193",
"name": "Sandoz Ltd",
"identifier": {
"legalName": "Sandoz Ltd"
},
"address": {
"streetAddress": "Frimley Business Park, Frimley",
"locality": "Camberley",
"region": "UKM",
"postalCode": "GU16 7SR"
},
"roles": [
"supplier"
],
"details": {
"scale": "large",
"url": "http://"
}
},
{
"id": "org-194",
"name": "Pfizer Ltd",
"identifier": {
"legalName": "Pfizer Ltd"
},
"address": {
"streetAddress": "Walton Oaks, Dorking Road, Surrey",
"locality": "Tadworth",
"region": "UKM",
"postalCode": "KT20 7NS"
},
"roles": [
"supplier"
],
"details": {
"scale": "large",
"url": "http://"
}
},
{
"id": "org-195",
"name": "Biogen Idec Ltd.",
"identifier": {
"legalName": "Biogen Idec Ltd."
},
"address": {
"streetAddress": "Innovation House, 70 Norden Road",
"locality": "Maidenhead",
"region": "UKM",
"postalCode": "SL4 6AY"
},
"roles": [
"supplier"
],
"details": {
"scale": "large",
"url": "http://"
}
},
{
"id": "org-196",
"name": "Merck Sharp & Dohme",
"identifier": {
"legalName": "Merck Sharp & Dohme"
},
"address": {
"streetAddress": "Hertford Road",
"locality": "Hoddesdon",
"region": "UKM",
"postalCode": "EN119BU"
},
"roles": [
"supplier"
],
"details": {
"scale": "large",
"url": "http://"
}
},
{
"id": "org-197",
"name": "Celltrion Healthcare United Kingdom Limited",
"identifier": {
"legalName": "Celltrion Healthcare United Kingdom Limited"
},
"address": {
"streetAddress": "1-7 The Switch",
"locality": "Slough",
"region": "UKM",
"postalCode": "SL1 1QP"
},
"roles": [
"supplier"
],
"details": {
"scale": "sme",
"url": "http://"
}
},
{
"id": "org-198",
"name": "AbbVie Ltd",
"identifier": {
"legalName": "AbbVie Ltd"
},
"address": {
"streetAddress": "Abbvie House, Vanwall Business Park",
"locality": "Maidenhead",
"region": "UKM",
"postalCode": "SL6 4UB"
},
"roles": [
"supplier"
],
"details": {
"scale": "large",
"url": "http://"
}
},
{
"id": "org-199",
"name": "amgen ltd",
"identifier": {
"legalName": "amgen ltd"
},
"address": {
"streetAddress": "240 cambridge science parl",
"locality": "cambrdige",
"region": "UKM",
"postalCode": "cb4 0wd"
},
"roles": [
"supplier"
],
"details": {
"scale": "large",
"url": "http://"
}
},
{
"id": "org-200",
"name": "Fresenius Kabi Limited",
"identifier": {
"legalName": "Fresenius Kabi Limited"
},
"address": {
"streetAddress": "Cestrian Court, Eastgate Way, Manor Park",
"locality": "Runcorn",
"region": "UKM",
"postalCode": "WA7 1NT"
},
"roles": [
"supplier"
],
"details": {
"scale": "large",
"url": "http://"
}
},
{
"id": "org-201",
"name": "Accord-UK Ltd",
"identifier": {
"legalName": "Accord-UK Ltd"
},
"address": {
"streetAddress": "Whiddon Valley",
"locality": "Barnstaple",
"region": "UKM",
"postalCode": "EX32 8NS"
},
"roles": [
"supplier"
],
"details": {
"scale": "large",
"url": "http://"
}
},
{
"id": "org-202",
"name": "medac Pharma LLP",
"identifier": {
"legalName": "medac Pharma LLP"
},
"address": {
"streetAddress": "Scion House, Innovation Park",
"locality": "Stirling",
"region": "UKM",
"postalCode": "FK9 4NF"
},
"roles": [
"supplier"
],
"details": {
"scale": "large",
"url": "http://"
}
},
{
"id": "org-203",
"name": "Accord UK Ltd",
"identifier": {
"legalName": "Accord UK Ltd"
},
"address": {
"streetAddress": "Whiddon Valley",
"locality": "Barnstaple",
"region": "UKM",
"postalCode": "EX32 8NS"
},
"roles": [
"supplier"
],
"details": {
"scale": "large",
"url": "http://"
}
},
{
"id": "org-204",
"name": "Nordic Pharma Ltd",
"identifier": {
"legalName": "Nordic Pharma Ltd"
},
"address": {
"streetAddress": "Unit 3, Commerce Park, Brunel Road",
"locality": "Theale",
"region": "UKM",
"postalCode": "RG7 4AB"
},
"roles": [
"supplier"
],
"details": {
"scale": "sme",
"url": "http://"
}
},
{
"id": "org-71",
"name": "Sheriff Court House",
"identifier": {
"legalName": "Sheriff Court House"
},
"address": {
"streetAddress": "27 Chambers Street",
"locality": "Edinburgh",
"postalCode": "EH1 1LB"
},
"contactPoint": {
"email": "edinburgh@scotcourts.gov.uk",
"telephone": "+44 1312252525",
"url": "http://"
},
"roles": [
"reviewBody"
]
}
],
"buyer": {
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")",
"id": "org-21"
},
"tender": {
"id": "NP47920",
"title": "Cytokine Modulators",
"description": "Supply of Cytokine Modulators to NHS Scotland which is used to treat licensed indications. Etanercept Infliximab Adalimumab Methotrexate The Goods have been split into eight (8) categories, each of which are identified as a \"Lot\". Full details of each Lot are contained in section II.2 of this notice.",
"status": "complete",
"items": [
{
"id": "4",
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
},
{
"region": "UKM"
}
],
"relatedLot": "4"
},
{
"id": "1",
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
},
{
"region": "UKM"
}
],
"relatedLot": "1"
},
{
"id": "2",
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
},
{
"region": "UKM"
}
],
"relatedLot": "2"
},
{
"id": "5",
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
},
{
"region": "UKM"
}
],
"relatedLot": "5"
},
{
"id": "6",
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
},
{
"region": "UKM"
}
],
"relatedLot": "6"
},
{
"id": "7",
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
},
{
"region": "UKM"
}
],
"relatedLot": "7"
},
{
"id": "8",
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
},
{
"region": "UKM"
}
],
"relatedLot": "8"
},
{
"id": "3",
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
},
{
"region": "UKM"
}
],
"relatedLot": "3"
}
],
"value": {
"amount": 146393864,
"currency": "GBP"
},
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure",
"mainProcurementCategory": "goods",
"submissionMethod": [
"electronicSubmission"
],
"submissionMethodDetails": "https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html",
"tenderPeriod": {
"endDate": "2020-11-12T12:00:00Z"
},
"awardPeriod": {
"startDate": "2020-11-12T12:00:00Z"
},
"documents": [
{
"id": "OCT396897",
"documentType": "contractNotice",
"title": "Cytokine Modulators",
"description": "Supply of Cytokine Modulators to NHS Scotland. Etanercept Infliximab Adalimumab Methotrexate The Goods have been split into eight (8) categories, each of which are identified as a \"Lot\". Full details of each Lot are contained in section II.2 of this notice.",
"url": "https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=OCT396897",
"format": "text/html"
},
{
"id": "FEB406448",
"documentType": "awardNotice",
"title": "Cytokine Modulators",
"description": "Supply of Cytokine Modulators to NHS Scotland which is used to treat licensed indications. Etanercept Infliximab Adalimumab Methotrexate The Goods have been split into eight (8) categories, each of which are identified as a \"Lot\". Full details of each Lot are contained in section II.2 of this notice.",
"url": "https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=FEB406448",
"format": "text/html"
}
],
"lots": [
{
"id": "4",
"title": "Adalimumab",
"description": "Supply of Adalimumab to NHS Scotland. The Authority has awarded this Lot as a unranked multi-supplier framework per line to five (5) Framework Participants.",
"status": "complete",
"value": {
"amount": 60835914,
"currency": "GBP"
},
"awardCriteria": {
"criteria": [
{
"type": "quality",
"name": "Supply Chain",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"hasOptions": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"contractPeriod": {
"durationInDays": 720
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option(s) to extend for up to a total period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
}
},
{
"id": "1",
"title": "Etanercept",
"description": "Supply of Etanercept to NHS Scotland. The Authority has awarded this Lot as a unranked multi-supplier framework per line to three (3) Framework Participants.",
"status": "complete",
"value": {
"amount": 46271726,
"currency": "GBP"
},
"awardCriteria": {
"criteria": [
{
"type": "quality",
"name": "Supply Chain",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"hasOptions": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"contractPeriod": {
"durationInDays": 720
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option(s) to extend for up to a total period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
}
},
{
"id": "2",
"title": "Infliximab IV",
"description": "Supply of Infliximab IV to NHS Scotland. The Authority has awarded this Lot as a unranked multi-supplier framework per line to five (5) Framework Participants.",
"status": "complete",
"value": {
"amount": 18784068,
"currency": "GBP"
},
"awardCriteria": {
"criteria": [
{
"type": "quality",
"name": "Supply Chain",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"hasOptions": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"contractPeriod": {
"durationInDays": 720
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option(s) to extend for up to a total period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
}
},
{
"id": "5",
"title": "Methotrexate (50 mg per 1 ml concentration ) pre-filled self injection device",
"description": "Supply of Methotrexate (50 mg per 1 ml concentration ) pre-filled self injection device to NHS Scotland. The Authority has awarded this Lot as a unranked multi-supplier framework per line to two (2) Framework Participants.",
"status": "complete",
"value": {
"amount": 18947932,
"currency": "GBP"
},
"awardCriteria": {
"criteria": [
{
"type": "quality",
"name": "Supply Chain",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"hasOptions": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"contractPeriod": {
"durationInDays": 720
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option(s) to extend for up to a total period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
}
},
{
"id": "6",
"title": "Methotrexate (50 mg per 1 ml concentration ) pre-filled syringes",
"description": "Supply of Methotrexate (50 mg per 1 ml concentration ) pre-filled syringes to NHS Scotland. The Authority has awarded this Lot as a unranked multi-supplier framework per line to one (1) Framework Participant.",
"status": "complete",
"value": {
"amount": 482418,
"currency": "GBP"
},
"awardCriteria": {
"criteria": [
{
"type": "quality",
"name": "Supply Chain",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"hasOptions": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"contractPeriod": {
"durationInDays": 720
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option(s) to extend for up to a total period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
}
},
{
"id": "7",
"title": "Methotrexate (25 mg per 1 ml concentration ) pre-filled self injection device",
"description": "Supply of Methotrexate (25mg per 1 ml concentration ) pre-filled self injection device to NHS Scotland. The Authority has awarded this Lot as a unranked multi-supplier framework per line to one (1) Framework Participant.",
"status": "complete",
"value": {
"amount": 298263,
"currency": "GBP"
},
"awardCriteria": {
"criteria": [
{
"type": "quality",
"name": "Supply Chain",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"hasOptions": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"contractPeriod": {
"durationInDays": 720
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option(s) to extend for up to a total period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
}
},
{
"id": "8",
"title": "Methotrexate (25mg per 1 ml concentration ) pre-filled syringes",
"description": "Supply of Methotrexate (25 mg per 1 ml concentration) pre-filled syringes to NHS Scotland. The Authority has awarded this Lot as a unranked multi-supplier framework per line to one (1) Framework Participant.",
"status": "complete",
"value": {
"amount": 465862,
"currency": "GBP"
},
"awardCriteria": {
"criteria": [
{
"type": "quality",
"name": "Supply Chain",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"hasOptions": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"contractPeriod": {
"durationInDays": 720
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option(s) to extend for up to a total period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
}
},
{
"id": "3",
"title": "Infliximab Subcutaneous",
"description": "Supply of Infliximab Subcutaneous to NHS Scotland. The Authority has awarded this Lot as a single supplier framework per line to one (1) Framework Participant.",
"status": "complete",
"value": {
"amount": 307680,
"currency": "GBP"
},
"awardCriteria": {
"criteria": [
{
"type": "quality",
"name": "Supply Chain",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"hasOptions": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"contractPeriod": {
"durationInDays": 720
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option(s) to extend for up to a total period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
}
}
],
"lotDetails": {
"maximumLotsBidPerSupplier": 2147483647
},
"participationFees": [
{
"id": "1",
"type": [
"document"
]
}
],
"bidOpening": {
"date": "2020-11-12T12:00:00Z"
},
"contractTerms": {
"hasElectronicPayment": true,
"hasElectronicOrdering": true,
"electronicInvoicingPolicy": "allowed"
},
"coveredBy": [
"GPA"
],
"selectionCriteria": {
"criteria": [
{
"type": "technical",
"description": "(a) Potential Framework Participants must be able to demonstrate that a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by the MHRA will be in place for all tendered Goods prior to the start date of the Framework Agreement. (b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent. (c) All tendered Goods must comply with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency (\"NPSA\") Guidelines on Packaging and Labelling on pack design.",
"minimum": "(a) Confirmation that a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by the MHRA will be in place for all tendered Goods prior to the start of the Framework Agreement should be included in the Qualification Envelope of the ITT under the Technical and Professional ability: Quality Control. (b) Confirmation of the existence of valid certification of BS EN ISO 9001 or equivalent. Confirmation of such certification should be included in the Qualification Envelope of the ITT under the Quality Assurance Schemes. (c) Confirmation that samples for tendered Goods will be supplied upon request to ensure compliance with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency (\"NPSA\") Guidelines on Packaging and Labelling on pack design. Confirmation of sample provision should be provided in the Qualification Envelope of the ITT under Technical and Professional ability: Products."
}
]
},
"submissionTerms": {
"languages": [
"en"
]
},
"techniques": {
"hasFrameworkAgreement": true,
"frameworkAgreement": {
"maximumParticipants": 6
}
},
"classification": {
"id": "33600000",
"scheme": "CPV"
},
"reviewDetails": "Economic operators should approach the contracting authority in the first instance. However, the only formal remedy is to apply to the courts: An economic operator that suffers, or is at risk of suffering, loss or damage attributable to a breach of duty under the Public Contracts (Scotland) Regulations 2015 or the Procurement Reform (Scotland) Act 2014, may bring proceedings in the Sheriff Court or the Court of Session.",
"hasRecurrence": false,
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
}
},
"language": "EN",
"description": "The estimated values referred to in Section II.I.5 and all Lots cover the initial twenty four (24) month duration and the maximum twenty four (24) month extension period. (SC Ref:642734)",
"links": [
{
"rel": "canonical",
"href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000631656"
},
{
"rel": "canonical",
"href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000631656"
}
],
"noticetype": "OJEU - F3 - Contract Award Notice",
"awards": [
{
"id": "NP47920-1",
"title": "Etanercept",
"suppliers": [
{
"id": "org-193",
"name": "Sandoz Ltd"
},
{
"id": "org-194",
"name": "Pfizer Ltd"
},
{
"id": "org-195",
"name": "Biogen Idec Ltd."
}
],
"relatedLots": [
"1"
]
},
{
"id": "NP47920-2",
"title": "Infliximab IV",
"suppliers": [
{
"id": "org-194",
"name": "Pfizer Ltd"
},
{
"id": "org-196",
"name": "Merck Sharp & Dohme"
},
{
"id": "org-197",
"name": "Celltrion Healthcare United Kingdom Limited"
},
{
"id": "org-195",
"name": "Biogen Idec Ltd."
},
{
"id": "org-193",
"name": "Sandoz Ltd"
}
],
"relatedLots": [
"2"
]
},
{
"id": "NP47920-3",
"title": "Infliximab Subcutaneous",
"suppliers": [
{
"id": "org-197",
"name": "Celltrion Healthcare United Kingdom Limited"
}
],
"relatedLots": [
"3"
]
},
{
"id": "NP47920-4",
"title": "Adalimumab",
"suppliers": [
{
"id": "org-198",
"name": "AbbVie Ltd"
},
{
"id": "org-199",
"name": "amgen ltd"
},
{
"id": "org-200",
"name": "Fresenius Kabi Limited"
},
{
"id": "org-195",
"name": "Biogen Idec Ltd."
},
{
"id": "org-193",
"name": "Sandoz Ltd"
}
],
"relatedLots": [
"4"
]
},
{
"id": "NP47920-5",
"title": "Methotrexate (50 mg per 1 ml concentration ) pre-filled self injection device",
"suppliers": [
{
"id": "org-201",
"name": "Accord-UK Ltd"
},
{
"id": "org-202",
"name": "medac Pharma LLP"
}
],
"relatedLots": [
"5"
]
},
{
"id": "NP47920-6",
"title": "Methotrexate (50 mg per 1 ml concentration ) pre-filled syringes",
"suppliers": [
{
"id": "org-203",
"name": "Accord UK Ltd"
}
],
"relatedLots": [
"6"
]
},
{
"id": "NP47920-7",
"title": "Methotrexate (25 mg per 1 ml concentration ) pre-filled self injection device",
"suppliers": [
{
"id": "org-204",
"name": "Nordic Pharma Ltd"
}
],
"relatedLots": [
"7"
]
},
{
"id": "NP47920-8",
"title": "Methotrexate (25mg per 1 ml concentration ) pre-filled syringes",
"suppliers": [
{
"id": "org-204",
"name": "Nordic Pharma Ltd"
}
],
"relatedLots": [
"8"
]
}
],
"contracts": [
{
"id": "NP47920-1",
"awardID": "NP47920-1",
"title": "Etanercept",
"status": "active",
"value": {
"amount": 46271726,
"currency": "GBP"
},
"dateSigned": "2021-01-11T00:00:00Z"
},
{
"id": "NP47920-2",
"awardID": "NP47920-2",
"title": "Infliximab IV",
"status": "active",
"value": {
"amount": 18193906,
"currency": "GBP"
},
"dateSigned": "2021-01-11T00:00:00Z"
},
{
"id": "NP47920-3",
"awardID": "NP47920-3",
"title": "Infliximab Subcutaneous",
"status": "active",
"value": {
"amount": 307680,
"currency": "GBP"
},
"dateSigned": "2021-01-11T00:00:00Z"
},
{
"id": "NP47920-4",
"awardID": "NP47920-4",
"title": "Adalimumab",
"status": "active",
"value": {
"amount": 36167709,
"currency": "GBP"
},
"dateSigned": "2021-01-11T00:00:00Z"
},
{
"id": "NP47920-5",
"awardID": "NP47920-5",
"title": "Methotrexate (50 mg per 1 ml concentration ) pre-filled self injection device",
"status": "active",
"value": {
"amount": 14775961,
"currency": "GBP"
},
"dateSigned": "2021-01-11T00:00:00Z"
},
{
"id": "NP47920-6",
"awardID": "NP47920-6",
"title": "Methotrexate (50 mg per 1 ml concentration ) pre-filled syringes",
"status": "active",
"value": {
"amount": 390136,
"currency": "GBP"
},
"dateSigned": "2021-01-11T00:00:00Z"
},
{
"id": "NP47920-7",
"awardID": "NP47920-7",
"title": "Methotrexate (25 mg per 1 ml concentration ) pre-filled self injection device",
"status": "active",
"value": {
"amount": 218102,
"currency": "GBP"
},
"dateSigned": "2021-01-11T00:00:00Z"
},
{
"id": "NP47920-8",
"awardID": "NP47920-8",
"title": "Methotrexate (25mg per 1 ml concentration ) pre-filled syringes",
"status": "active",
"value": {
"amount": 317995,
"currency": "GBP"
},
"dateSigned": "2021-01-11T00:00:00Z"
}
],
"relatedProcesses": [
{
"id": "1",
"relationship": [
"planning"
],
"scheme": "EU-OJ",
"identifier": "2020/S 199-483802"
}
],
"bids": {
"statistics": [
{
"id": "384",
"measure": "bids",
"value": 3,
"relatedLot": "1"
},
{
"id": "385",
"measure": "smeBids",
"value": 0,
"relatedLot": "1"
},
{
"id": "386",
"measure": "foreignBidsFromEU",
"value": 0,
"relatedLot": "1"
},
{
"id": "387",
"measure": "foreignBidsFromNonEU",
"value": 3,
"relatedLot": "1"
},
{
"id": "388",
"measure": "electronicBids",
"value": 3,
"relatedLot": "1"
},
{
"id": "389",
"measure": "bids",
"value": 5,
"relatedLot": "2"
},
{
"id": "390",
"measure": "smeBids",
"value": 1,
"relatedLot": "2"
},
{
"id": "391",
"measure": "foreignBidsFromEU",
"value": 0,
"relatedLot": "2"
},
{
"id": "392",
"measure": "foreignBidsFromNonEU",
"value": 5,
"relatedLot": "2"
},
{
"id": "393",
"measure": "electronicBids",
"value": 5,
"relatedLot": "2"
},
{
"id": "394",
"measure": "bids",
"value": 1,
"relatedLot": "3"
},
{
"id": "395",
"measure": "smeBids",
"value": 1,
"relatedLot": "3"
},
{
"id": "396",
"measure": "foreignBidsFromEU",
"value": 0,
"relatedLot": "3"
},
{
"id": "397",
"measure": "foreignBidsFromNonEU",
"value": 1,
"relatedLot": "3"
},
{
"id": "398",
"measure": "electronicBids",
"value": 1,
"relatedLot": "3"
},
{
"id": "399",
"measure": "bids",
"value": 5,
"relatedLot": "4"
},
{
"id": "400",
"measure": "smeBids",
"value": 0,
"relatedLot": "4"
},
{
"id": "401",
"measure": "foreignBidsFromEU",
"value": 0,
"relatedLot": "4"
},
{
"id": "402",
"measure": "foreignBidsFromNonEU",
"value": 5,
"relatedLot": "4"
},
{
"id": "403",
"measure": "electronicBids",
"value": 5,
"relatedLot": "4"
},
{
"id": "404",
"measure": "bids",
"value": 2,
"relatedLot": "5"
},
{
"id": "405",
"measure": "smeBids",
"value": 1,
"relatedLot": "5"
},
{
"id": "406",
"measure": "foreignBidsFromEU",
"value": 0,
"relatedLot": "5"
},
{
"id": "407",
"measure": "foreignBidsFromNonEU",
"value": 2,
"relatedLot": "5"
},
{
"id": "408",
"measure": "electronicBids",
"value": 2,
"relatedLot": "5"
},
{
"id": "409",
"measure": "bids",
"value": 1,
"relatedLot": "6"
},
{
"id": "410",
"measure": "smeBids",
"value": 0,
"relatedLot": "6"
},
{
"id": "411",
"measure": "foreignBidsFromEU",
"value": 0,
"relatedLot": "6"
},
{
"id": "412",
"measure": "foreignBidsFromNonEU",
"value": 1,
"relatedLot": "6"
},
{
"id": "413",
"measure": "electronicBids",
"value": 1,
"relatedLot": "6"
},
{
"id": "414",
"measure": "bids",
"value": 1,
"relatedLot": "7"
},
{
"id": "415",
"measure": "smeBids",
"value": 1,
"relatedLot": "7"
},
{
"id": "416",
"measure": "foreignBidsFromEU",
"value": 0,
"relatedLot": "7"
},
{
"id": "417",
"measure": "foreignBidsFromNonEU",
"value": 1,
"relatedLot": "7"
},
{
"id": "418",
"measure": "electronicBids",
"value": 1,
"relatedLot": "7"
},
{
"id": "419",
"measure": "bids",
"value": 1,
"relatedLot": "8"
},
{
"id": "420",
"measure": "smeBids",
"value": 1,
"relatedLot": "8"
},
{
"id": "421",
"measure": "foreignBidsFromEU",
"value": 0,
"relatedLot": "8"
},
{
"id": "422",
"measure": "foreignBidsFromNonEU",
"value": 1,
"relatedLot": "8"
},
{
"id": "423",
"measure": "electronicBids",
"value": 1,
"relatedLot": "8"
}
]
}
}